SAN FRANCISCO – November 06, 2026 -- AusperBio's investigational antisense oligonucleotide AHB-137 maintained functional cure in 16 of 17 evaluable nucleos(t)ide analogue (NA)-treated chronic hepatitis B participants 12 months after they stopped all HBV treatment, according to long-term follow-up data from Study AB-10-8004. No participant required NA re-initiation during follow-up.

Nine of nine evaluable NA-treated participants stay cured at 15 months

In the NA-treated cohort, functional cure held in 9 of 9 evaluable participants at 15 months after NA discontinuation. The cohort enrolled 34 participants (21 complete responders, 13 partial responders) from the Phase 2 studies AB-10-8002 and AB-10-8003.

Durham – November 06, 2026 -- Brii Biosciences (2137.HK) reported that 41.9% of participants (62/148) in its Phase 2b ENRICH study achieved hepatitis B surface antigen (HBsAg) loss at end of treatment (EOT), with 32.4% (48/148) sustaining it 24 weeks later. The data were presented in three late-breaking sessions at the AASLD Liver Meeting in Denver, running November 5 to 9, 2026.

ENRICH reproduces the BRII-179 priming effect seen in ENSURE Cohort 4

ENRICH prospectively tested a strategy first identified in Cohort 4 of the ENSURE study, where BRII-179-experienced participants, particularly those developing anti-HBs responses, showed higher functional cure rates. Participants received BRII-179 every 3 or 2 weeks for 12 weeks before elebsiran and pegylated interferon alpha (PEG-IFNα). Results across both dose regimens matched the ENSURE observations.

Franklin, N.C. – November 06, 2026 -- Drake Software will sell its AI-driven Drake SmartExtract tool from December at $5 per return, with package pricing as low as $1.50 per return for 100 or more returns. The launch is part of a broader AI rollout across software used by more than 70,000 tax professionals.

Drake is adding three AI capabilities for the coming season: SmartExtract (currently in beta), a redesigned Drake Portals client experience, and an AI Assistant embedded in Drake Tax and Drake Tax Online. Drake says it developed them with its customers. Pricing is subject to change.

SmartExtract maps client documents to return fields

SmartExtract, available in beta for Drake Tax and Drake Tax Online, pulls data from supported documents and maps it to the matching return fields. Preparers review and adjust the extracted data before it enters the return, which cuts manual rekeying.

BELLEVUE – November 06, 2026 -- Harrison Street Asset Management, a firm with more than $110 billion in assets under management, has formed a joint venture with Aegis Living to invest in and develop assisted living and memory care communities, starting with a three-property portfolio.

Initial portfolio covers three Aegis communities in Washington and California

The first investment spans Aegis Gardens in Newcastle, WA; Aegis Living Moraga in Moraga, CA; and Aegis Living Madison in Seattle. The partners plan to add acquisitions and development projects. Financial terms were not included in the announcement.

Aegis Living will continue to manage all three communities. Care teams, community leaders and care plans stay in place. Aegis, founded in 1997 and based in Bellevue, operates 37 communities across Washington, California and Nevada.

HONG KONG – November 06, 2026 -- Fosun International received the "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal (HKEJ) on 5 November 2026, after its MSCI ESG Rating was raised to the highest tier, AAA.

HKEJ presented the award at its "ESG & Sustainability Awards of Excellence 2026" ceremony. Other recipients included Henderson Land Development, China Overseas Land & Investment, FWD Life Insurance, Bank of China (Hong Kong) and China Minsheng Bank Hong Kong Branch. HKEJ linked the awards to the Hong Kong government's first Five-Year Plan for Economic and Social Development (2026-2030), which sets green development and environmental protection targets.

Seoul – November 06, 2026 -- Coway Co., Ltd. reported third-quarter 2026 revenue of KRW 1,426.1 billion, up 13.7% year on year, while operating profit rose 7.3% to KRW 260.8 billion. The figures are consolidated under K-IFRS.

Overseas subsidiaries grow revenue 26.2% to KRW 591.8 billion

Coway's foreign units grew faster than the domestic business, with sales up across all product categories. Malaysia remained the largest contributor at KRW 428.0 billion, up 21.5%.

The smaller markets grew faster:

• United States: KRW 83.9 billion, up 45.8%
• Thailand: KRW 57.7 billion, up 38.0%
• Indonesia: KRW 16.0 billion, up 21.8%

Domestic revenue rises 2.0% to KRW 754.9 billion as rental accounts surge

Seasonal promotions supported sales of ice water purifiers, beds and massage chairs. New rental sales volume grew 7.3% year on year, and net rental account additions jumped 26.7% to 214,000.

Addison, Texas – November 06, 2026 -- FX Shoulder Solutions has received FDA 510(k) clearance for Easytech Reversed, which the company describes as the first and only stemless reverse shoulder arthroplasty system cleared in the United States. The clearance follows nearly eight years of US clinical investigation.

Seven-site IDE study enrolled 90 patients

FX started the US Investigational Device Exemption (IDE) study in 2018. The multicenter investigation ran across seven sites and covered 90 patients. Follow-up was completed in 2023 and supports the regulatory submission, according to the company. FX also cites more than a decade of international clinical experience with its Easytech technology.

Shanghai – November 06, 2026 -- Antengene Corporation Limited (SEHK: 6996.HK) has dosed the first patient in China in the Phase I ATTRACT study of ATG-201, its CD19 x CD3 bispecific T-cell engager (TCE) for adult patients with B cell-mediated autoimmune diseases. UCB holds worldwide exclusive rights to develop, manufacture and commercialize the asset.

UCB holds global rights while Antengene runs Phase I in China and Australia

Under the agreement, UCB also gains access to the manufacturing technology associated with ATG-201. Antengene remains responsible for conducting the Phase I trials in China and Australia.

The Australian arm has cleared its regulatory steps. ATG-201 has obtained approval from the Human Research Ethics Committee (HREC) and completed the Clinical Trial Notification (CTN) process with the Therapeutic Goods Administration (TGA).

Geneva – November 06, 2026 -- Education Cannot Wait (ECW) secured US$405.8 million in new government pledges at its High-Level Replenishment Conference, hosted by Switzerland. Combined with US$135.8 million already committed through earlier multi-year donor agreements, the total for its Hope Starts Here campaign reaches US$541.6 million, or 90% of the US$600 million target. That leaves a gap of US$58.4 million.

Eight governments and the EU lead the pledging round

Germany, the United Kingdom, Norway, Canada, Switzerland, Ireland, the EU and Japan were among the contributors. Switzerland pledged CHF 35 million to ECW for 2027 to 2030. The fund received the commitments as humanitarian needs grow and international aid budgets shrink.

MILWAUKEE – November 06, 2026 -- Western Products is auctioning a one-of-a-kind America 250-themed pusher plow, with 100% of proceeds going to Camp Hometown Heroes. The manufacturer's earlier military auctions have already raised more than $110,000 for the charity.

Bidding on the custom-wrapped PILE DRIVER plow closes at 11:11 a.m. CST on Nov. 11

The auction runs from Nov. 1 through Nov. 11, 2026, on the official WESTERN Facebook page, where participants can track active bids and place offers. The lot is a WESTERN PILE DRIVER pusher plow, custom-wrapped to commemorate 250 years of the United States. The company announced it earlier this year at the Snow & Ice Symposium.

Bidding closes at 11:11 a.m. Central Standard Time on Wednesday, Nov. 11, 2026. The timing references the end of major hostilities in World War I at the 11th hour of the 11th day of the 11th month of 1918. That date became Armistice Day and was later renamed Veterans Day.